FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Avkare Phytonadione Tablets 5 mg Recall

Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKA…

AVKARE Inc. · Pulaski, TN

Risk level
Class III
Reported by FDA
Jun 23, 2021
Recall ID
D-0631-2021
Check your lot numberHow we source this data

Summary

Avkare recalled Phytonadione Tablets 5 mg starting Jun 9, 2021. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0631-2021 on Jun 23, 2021. Reason: Failed Impurities Specification: Out of specification when measuring the impurity degradant D level. Status: Terminated.

Why it was recalled

Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

Product description

Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13

Lot numbers, UPCs & expiration codes

Lot: 38617 Exp. 10/2022

Where it was sold

Distributed in Los Angeles California

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0631-2021
Classification
Class III
Status
Terminated
Recall initiated
Jun 9, 2021
FDA report date
Jun 23, 2021
Quantity
10 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
AVKARE Inc.

Original FDA data

Every field from FDA enforcement report D-0631-2021, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Terminated
Country
United States
Event ID
88091
Address
615 N 1st St
Code information
Lot: 38617 Exp. 10/2022
Postal code
38478-2403
Report date
Jun 23, 2021
Product type
Drugs
Recall number
D-0631-2021
Classification
Class III
Recalling firm
AVKARE Inc.
Product quantity
10 cartons
Termination date
Jun 2, 2023
Reason for recall
Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13
Distribution pattern
Distributed in Los Angeles California
Recall initiation date
Jun 9, 2021
Initial firm notification
Letter
Center classification date
Jun 16, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0631-2021, published Jun 23, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls